REMICADE
INFLIXIMAB
Public price
4,58 MAD
Active substance
INFLIXIMAB
Laboratory
MAPHAR
What is this medicine?
Infliximab is a tumor necrosis factor (TNF) blocker.
Verified summary
INFLIXIMAB, POUDRE LYOPHILISEE POUR SOLUTION A DILUER POUR PERFUSION, 100 MG, FLACON DE 20 ML
Common uses
Crohn's Disease,Pediatric Crohn's Disease,Ulcerative Colitis,Pediatric Ulcerative Colitis,Rheumatoid Arthritis,Ankylosing Spondylitis,Psoriatic Arthritis,Plaque Psoriasis
Class
Tumor necrosis factor (TNF) blocker
Laboratory
MAPHAR
Hospital price
4,30 MAD
Strength
100 MG
Form
POUDRE LYOPHILISEE POUR SOLUTION A DILUER POUR PERFUSION
Presentation
FLACON DE 20 ML
Commercial status
Commercialisé
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-01: 4,58 MAD
Available presentations and strengths
Medicines with the same active substance
REMSIMA SC
120 MG · BOITE DE 1 STYLO PREREMPLI DE 1 ML
2,23 MAD
REMSIMA SC
120 MG · BOITE DE 2 STYLOS PREREMPLIS DE 1 ML
4,07 MAD
REMSIMA
100 MG · BOITE D'UN FLACON
4,27 MAD
REMSIMA SC
120 MG · BOITE DE 4 STYLOS PREREMPLIS DE 1 ML
6,27 MAD
REMSIMA SC 120 MG
120 MG · Boite de 2
4.067,00 MAD
REMSIMA 100 MG
100 MG · 1 flacon
4.267,00 MAD